or Try an Advanced Search...

    Technical Analysis for ARQT - Arcutis Biotherapeutics, Inc.

    Grade Last Price % Change Price Change
    C 10.14 -0.98% -0.10
    ARQT closed down 0.98 percent on Friday, November 22, 2024, on 54 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Up Up
    Historical ARQT trend table...
    Date Alert Name Type % Chg
    NR7 Range Contraction 0.00%
    Inside Day Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    Doji - Bearish? Reversal -0.98%
    Wide Bands Range Expansion -0.98%
    Up 3 Days in a Row Strength -0.98%
    Up 4 Days in a Row Strength -0.98%
    NR7 Range Contraction -0.39%
    Multiple of Ten Bullish Other -0.39%
    Wide Bands Range Expansion -0.39%
    Older End-of-Day Signals for ARQT ...

       Recent Intraday Alerts

    Alert Time
    Possible NR7 about 15 hours ago
    Possible Inside Day about 15 hours ago
    10 DMA Support about 19 hours ago
    Down 1% about 19 hours ago
    Up 1% about 19 hours ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    ARQT Chart by TradingView
    Basic chart:

    Profile

    Arcutis Biotherapeutics, Inc. engages in the development and commercialization of treatments for dermatological diseases. Its piepline consists of topical treatments for plaque psoriasis, atopic dermatitis, eczema, vitiligo, alopecia areata, and seborrheic dermatitis. The company was founded by Bhaskar Chaudhuri and David W. Osborne on June 1, 2016 and is headquartered in Westlake Village, CA.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Immunology Organ Systems Autoimmune Disease Psoriasis Atopic Dermatitis Dermatitis Type I Hypersensitivity Atopy Eczema Alopecia Areata Dermatological Diseases Plaque Psoriasis Vitiligo

    Is ARQT a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 2 bullish, 0 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 20 Arcutis Biotherapeutics, Inc. (ARQT) Recently Broke Out Above the 200-Day Moving Average
    Nov 20 Arcutis Biotherapeutics, Inc. (ARQT) Crossed Above the 50-Day Moving Average: What That Means for Investors
    Nov 19 Bears are Losing Control Over Arcutis Biotherapeutics (ARQT), Here's Why It's a 'Buy' Now
    Nov 19 Arcutis Biotherapeutics, Inc. (ARQT) Recently Broke Out Above the 20-Day Moving Average
    Nov 18 Arcutis Biotherapeutics: What Lies Ahead
    Nov 15 Arcutis Biotherapeutics: +200% On ZORYVE Approval, But When Is The Next Leg Up?
    Nov 13 Arcutis’ ZORYVE® (roflumilast) Awarded Best Eczema Treatment by Glamour
    Nov 11 Wall Street Analysts See a 70.33% Upside in Arcutis Biotherapeutics (ARQT): Can the Stock Really Move This High?
    Nov 8 Arcutis Biotherapeutics Third Quarter 2024 Earnings: Beats Expectations
    Nov 7 Arcutis Biotherapeutics, Inc. (ARQT) Q3 2024 Earnings Call Transcript
    See more ARQT news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 13.17
    52 Week Low 1.76
    Average Volume 2,046,826
    200-Day Moving Average 9.51
    50-Day Moving Average 9.56
    20-Day Moving Average 9.63
    10-Day Moving Average 10.08
    Average True Range 0.63
    RSI (14) 55.75
    ADX 19.67
    +DI 30.14
    -DI 20.76
    Chandelier Exit (Long, 3 ATRs) 9.54
    Chandelier Exit (Short, 3 ATRs) 10.09
    Upper Bollinger Bands 11.23
    Lower Bollinger Band 8.02
    Percent B (%b) 0.66
    BandWidth 33.25
    MACD Line 0.22
    MACD Signal Line 0.17
    MACD Histogram 0.0493
    Fundamentals Value
    Market Cap 981.48 Million
    Num Shares 96.8 Million
    EPS -4.33
    Price-to-Earnings (P/E) Ratio -2.34
    Price-to-Sales 13.14
    Price-to-Book 13.63
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 10.62
    Resistance 3 (R3) 10.64 10.51 10.54
    Resistance 2 (R2) 10.51 10.38 10.50 10.51
    Resistance 1 (R1) 10.32 10.31 10.26 10.30 10.49
    Pivot Point 10.19 10.19 10.15 10.18 10.19
    Support 1 (S1) 10.00 10.06 9.94 9.98 9.79
    Support 2 (S2) 9.87 9.99 9.86 9.77
    Support 3 (S3) 9.68 9.87 9.74
    Support 4 (S4) 9.66